✦ LIBER ✦

Lack of Pharmacokinetic Interaction between Esomeprazole and the Nonsteroidal Anti-Inflammatory Drugs Naproxen and Rofecoxib in Healthy Subjects

✍ Scribed by Dr M. Hassan-Alin, J. Naesdal, C. Nilsson-Pieschl, G. Långström, T. Andersson

Book ID: 119930053
Publisher: Springer International Publishing AG
Year: 2005
Tongue: English
Weight: 122 KB
Volume: 25
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200525110-00006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of drug-drug interaction between es

Lack of drug-drug interaction between esomeprazole and rofecoxib in healthy subjects

✍ Hassan-Alin, Mohammed; Nilsson-Pieschl, Catharina; Naesdal, Jorgen; Langstrom, G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Lack of drug-drug interaction between es

Lack of drug-drug interaction between esomeprazole and naproxen in healthy subjects

✍ Hassan-Alin, Mohammed; Nilsson-Pieschl, Catharina; Naesdal, Jorgen; Langstrom, G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Pharmacokinetic interactions between reb

Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats

✍ Cooper, Dustin L.; Wood, Robert C.; Wyatt, Jarrett E.; Harirforoosh, Sam 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 849 KB

Pharmacokinetic and pharmacodynamic inte

Pharmacokinetic and pharmacodynamic interaction between furosemide and the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen

✍ D. Jacobs; C. Paterson; S. Rasmussen; S. Youngberg; N. McGuinness 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Evaluation of the Pharmacokinetic Intera

Evaluation of the Pharmacokinetic Interaction between Lesogaberan (AZD3355) and Esomeprazole in Healthy Subjects

✍ Mohammad Niazi MSc, Pharm, Debra G. Silberg, Frank Miller, Magnus Ruth… 📂 Article 📅 2010 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 173 KB

Pharmacokinetics of the anti-inflammator

Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states

✍ I. W. Taylor; T. Taylor; I. James; G. Doyle; G. Dorf; A. Darragh; L. F. Chasseau 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 606 KB

The pharmacokinetics of ximoprofen, a potent new non-steroidal anti-inflammatory agent, has been investigated in normal healthy subjects and in patients with hepatic or renal disease. After intravenous infusion of 22.8 mg to healthy subjects, plasma ximoprofen concentrations declined in a polyexpone